CRH success at SRI conference
Many congratulations to Dr Mike Rimmer (Mitchell lab) and Aleks Tsolova (Critchley lab) who had great success at the 69th Annual Scientific Meeting of the SRI, in Denver Colorado.
Mike was awarded an Early Career Investigator Award for his research in extracellular vesicles in the pre-pubertal testis and Aleks was awarded the prize for Best New Investigator for outstanding poster presentation effectively furthering the objectives of the Society.
This conference took place in Colorado from 15-19 March 2022 and this year’s scientific program included 160 Oral Sessions, 12 invited Mini-Symposia with a great balance of investigators, invited Lunch and Learn Symposia and a Hot Topics Plenary Session.
CRH’s Aleks Tsolova said: “Thank you to everyone who stopped by to talk to me at the poster session. I had a truly fantastic time meeting so many people interested in the endometrium and in vitro models to study it. Science is progressing fast for this important, understudied and complex organ.”
Mike and Aleks both thoroughly enjoyed the conference and the networking opportunities. Here they are pictured with this year’s SRI president, Professor Nanette Santoro.
We extend our well wishes to them both following this well deserved recognition of their hard work.
Dr Mike Rimmer presented his work on:
Novel actions of chemotherapy on the release of extracellular vesicles in the prepubertal testis
Aleks Tsolova and her winning poster: Effect of Selective Progesterone Receptor Modulator (SPRM) Ulipristal Acetate (UPA) on Phenotypic Activity of Isolated Human Endometrial Stromal Cells, Epithelial Organoids, and a Stromal–Epithelial Co-Cultures Grown in Matrigel and Functionalised PEG Gel as Assessed by Reverse-Phase Protein Array: A Pilot Study
The Society for Reproductive Investigation Society (SRI) aims to advance reproductive and women’s health care through (1) outstanding basic, translational, and clinical science, (2) training and mentoring future generations of investigators, (3) advocacy targeting funding agencies, policy makers, donors and the community and, (4) promoting women’s health globally.